Mabtas 500 mg Injection
  1. Home
  2. Pharma Products
  3. Intas Pharmaceuticals Ltd
  4. Mabtas 500 mg Injection

Mabtas 500 mg Injection

Mabtas 500 mg Injection contains rituximab 500 mg, a monoclonal antibody used in the treatment of certain blood cancers and autoimmune conditions. It is used for conditions including non-Hodgkin lymphoma, chronic lymphocytic leukemia, and rheumatoid arthritis. The medicine is administered by intravenous infusion under the supervision of a qualified healthcare professional.

BUY NOW

Category

Rituximab works by targeting the CD20 protein on B-cells and helping the immune system eliminate abnormal or overactive B-cells. Depending on the condition, it may be used alone or in combination with chemotherapy or other medicines as part of a prescribed treatment regimen. Patients require monitoring during and after infusion because infusion-related reactions, infections, and changes in blood-cell counts can occur. The dosage and treatment schedule are individualized by the specialist according to the disease, clinical response, and patient factors.

Technical Specification

Specification Details
Active Ingredient Rituximab
Strength 500 mg
Concentration 10 mg/mL
Dosage Form Solution for Infusion
Route of Administration Intravenous Infusion
Pack Size 50 mL, 1 Vial

Product Also Known As

Mabtas 500mg Injection, Mabtas 500 mg Injection, Mabtas 500mg Infusion, Mabtas 500mg Vial, Rituximab 500mg Injection, Rituximab 500 mg Injection, Rituximab 500mg Infusion